Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscle Health)
Clinical trial NCT07527195 · RECRUITING
Trial details
- NCT number
- NCT07527195
- Sponsor
- Novo Nordisk A/S
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-10
- Primary completion
- 2028-04-28
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.